Applications of IR Biotyper in Clinical Microbiology

This technical report discusses the innovative applications of the Bruker IR Biotyper® at Cedars-Sinai Medical Center, focusing on its role in identifying and analyzing emerging pathogens, particularly Candida auris. The report outlines the challenges posed by Candida auris, a multidrug-resistant yeast that has rapidly spread across healthcare facilities. It details the comprehensive testing and research conducted by Dr. Margie Morgan and Dr. Deisy Contreras to improve identification methods for this pathogen. The document explains how the IR Biotyper is utilized for epidemiological surveillance and predictive trend analysis, enhancing the reliability and speed of microorganism identification. The report also highlights the development of a rapid surveillance test for Candida auris during the COVID-19 pandemic, showcasing the collaboration with Bruker for data interpretation and software support. Furthermore, it describes ongoing research into the discriminatory power of the IR Biotyper for other microorganisms, emphasizing its potential to improve clinical outcomes through faster and more accurate strain typing.